Anal cancer is a rare yet increasing cancer linked primarily to high-risk HPV strains such as HPV-16 and HPV-18. Key risk factors include weakened immune systems, age over 50, and high-risk sexual ...

Losing British drug giant AstraZeneca from the London Stock Exchange would be a “devastating blow”, Tory former chancellor ...

Cheng was a pioneer in clinical trials for tumour diseases, especially small-cell lung carcinoma A top Chinese oncologist and physician-scientist, Cheng Ying, has died suddenly aged 62, according to ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

The company's share price has received a boost in recent weeks after it was declared the successful bidder for UK small ...

London has struggled for several years to attract big-name IPOs amid a dearth of liquidity and a less favourable regulatory ...

Gilt yields spike on Reeves exit speculation and CEO of AstraZeneca discusses leaving London - Stock markets updates and business news from Wednesday ...

Bengaluru: Global biopharmaceutical company AstraZeneca is investing Rs166 crore to expand its Bengaluru operations, creating 400 new jobs. The upgrad.

AstraZeneca has launched a new Global Hub in Bengaluru, investing Rs 166 crore for AI healthcare solutions. This move aims to advance R&D, IT, and digital health operations, creating 400 new jobs. The ...

Chennai, Jun 26 (PTI) Global bio-pharmaceutical company AstraZeneca has established its state-of-the-art Global Hub in Bengaluru investing Rs 166 crore to focus on development of AI-powered healthcare ...

AstraZeneca British-Swedish drugmaker AstraZeneca said on June 26 it is doubling down on India’s innovation potential with a Rs 166 crore investment to expand its Global Hub in Bengaluru.

Find the latest AstraZeneca PLC (AZN) stock quote, history, news and other vital information to help you with your stock trading and investing.